Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gomeni

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Clinical Pharmacology and Therapeutics|March 26, 2010
Adaptive-optimal design in PET occupancy studiesS Zamuner, V L Di Iorio, J Nyberg, et al.
Psychopharmacologia|March 16, 1976
An integrated approach for the evaluation of psychotropic drug in man. I. Studies on amphetamine. Relationship between drug levels and psychophysiological measurementsP L Morselli, G F Placidi, C Maggini, et al.
Therapie|January 1, 1981
[Comparative pharmacokinetics of antrafenine in healthy volunteers and in patients with chronic renal failure (author's transl)]V Rovei, A Leroy, J P Sauvanet, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1992
Endotracheal and aerosol administrations of ceftazidime in patients with nosocomial pneumonia: pharmacokinetics and absolute bioavailabilityF Bressolle, J E de la Coussaye, R Ayoub, et al.
Clinical Pharmacokinetics|January 1, 1976
Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatmentG Bianchetti, G Graziani, D Brancaccio, et al.
Therapeutic Drug Monitoring|May 21, 2005
Population pharmacokinetics of mycophenolic acid in kidney transplant pediatric and adolescent patientsS Payen, D Zhang, A Maisin, et al.
British Journal of Clinical Pharmacology|March 1, 1980
Pharmacokinetics of SL 75212 and propranolol in old age, uraemia and in healthy young adults [proceedings]G Bianchetti, D Brancaccio, F Forette, et al.
British Journal of Clinical Pharmacology|October 1, 1979
Pharmacokinetics of the new beta-adrenoceptor blocker SL 75212 in man after repeated oral administration [proceedings]G Bianchetti, C Blatrix, R Gomeni, et al.
Arzneimittel-Forschung|January 1, 1980
Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administrationG Bianchetti, C Blatrix, R Gomeni, et al.
Journal of Psychopharmacology (Oxford, England)|March 1, 2008
Pharmacokinetics and time-course of D(2) receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patientsA M Catafau, M M Penengo, G Nucci, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Clinical Pharmacology and Therapeutics|March 26, 2010
Adaptive-optimal design in PET occupancy studiesS Zamuner, V L Di Iorio, J Nyberg, et al.
Psychopharmacologia|March 16, 1976
An integrated approach for the evaluation of psychotropic drug in man. I. Studies on amphetamine. Relationship between drug levels and psychophysiological measurementsP L Morselli, G F Placidi, C Maggini, et al.
Therapie|January 1, 1981
[Comparative pharmacokinetics of antrafenine in healthy volunteers and in patients with chronic renal failure (author's transl)]V Rovei, A Leroy, J P Sauvanet, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1992
Endotracheal and aerosol administrations of ceftazidime in patients with nosocomial pneumonia: pharmacokinetics and absolute bioavailabilityF Bressolle, J E de la Coussaye, R Ayoub, et al.
Clinical Pharmacokinetics|January 1, 1976
Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatmentG Bianchetti, G Graziani, D Brancaccio, et al.
Therapeutic Drug Monitoring|May 21, 2005
Population pharmacokinetics of mycophenolic acid in kidney transplant pediatric and adolescent patientsS Payen, D Zhang, A Maisin, et al.
British Journal of Clinical Pharmacology|March 1, 1980
Pharmacokinetics of SL 75212 and propranolol in old age, uraemia and in healthy young adults [proceedings]G Bianchetti, D Brancaccio, F Forette, et al.
British Journal of Clinical Pharmacology|October 1, 1979
Pharmacokinetics of the new beta-adrenoceptor blocker SL 75212 in man after repeated oral administration [proceedings]G Bianchetti, C Blatrix, R Gomeni, et al.
Arzneimittel-Forschung|January 1, 1980
Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administrationG Bianchetti, C Blatrix, R Gomeni, et al.
Journal of Psychopharmacology (Oxford, England)|March 1, 2008
Pharmacokinetics and time-course of D(2) receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patientsA M Catafau, M M Penengo, G Nucci, et al.
Pageof 11